THE SCIENCE BEHIND IT
Two of these four have an authorised claim. Two do not.
In the EU, only a short list of health claims is authorised. The omega-3s and the olive polyphenol are on it. Coenzyme Q10 and resveratrol had their claims looked at and rejected. Neither of the two claims that do apply says anything about lowering your LDL, and we would rather tell you that than write a sentence that sounds the same for all four.
EPA + DHA
AUTHORISED CLAIM
WHAT WE ARE ALLOWED TO SAY
“EPA and DHA contribute to the normal function of the heart.”
Regulation (EU) 432/2012, for a daily intake of 250 mg. This formula carries 1,500 mg, as re-esterified triglyceride rather than ethyl ester. The claim is about the heart, not about cholesterol, and we do not stretch it to cover your LDL.
Reg. 432/2012 · 250 mg a day minimum · 2 sources on file · 2 with a PMID
Coenzyme Q10
NO AUTHORISED CLAIM
WHAT WE ARE ALLOWED TO SAY
Nothing. EFSA rejected every claim put to it, so we make none.
EFSA looked at claims on energy, blood pressure, cholesterol and the protection of lipids from oxidation, among others, and turned them all down. It is here on published work, not on a claim. That is a reason to include it, not a permission to promise anything. The upper limit on file for coenzyme Q10 is 100 mg a day, from the German BfR; this formula alone carries 200 mg, twice that. The 200 mg figure is an internal note in our own ingredient file, aligned with the French ANSES reference, and it is what we hold a whole plan to. The two figures in our file do not agree yet, and we would rather say so than pick the larger one.
EFSA Journal 2010;8(10):1793 · 9 sources on file · 1 with a PMID · not a claim
Olive hydroxytyrosol
AUTHORISED CLAIM
WHAT WE ARE ALLOWED TO SAY
“Olive oil polyphenols contribute to the protection of blood lipids from oxidative stress.”
Regulation (EU) 432/2012, for a daily intake of 5 mg of hydroxytyrosol and its derivatives. This formula carries 25 mg, from an olive leaf extract with at least 40% hydroxytyrosol. The claim is about protecting blood lipids from oxidation, not about lowering them. No upper limit has been set for it.
Reg. 432/2012 · EFSA novel food opinion 2017 · 2 sources on file · 1 with a PMID
Resveratrol
NO AUTHORISED CLAIM
WHAT WE ARE ALLOWED TO SAY
Nothing. EFSA rejected its cardiovascular and antioxidant claims, so we make none.
Its approval as a novel food, up to 150 mg a day for adults, is about safety, not about an effect. Our file also notes that very little of it reaches the blood intact, around 1%. This formula carries 100 mg: our file lists 150 mg as the lowest effective dose and marks this one as reduced for safety. That is a reason to be careful with it, not a permission to promise anything.
EFSA Journal 2010;8(10):1489 · novel food, 150 mg a day · 9 sources on file · 1 with a PMID · claim rejected